Women's Health

Awareness on the leading cause of death in women — heart disease — declined from 2009 to 2019, particularly in non-Hispanic Black and Hispanic women, and in younger women, an American Heart Association survey found.

Adverse pregnancy outcomes, particularly hypertensive disorders of pregnancy and low birth weight, were independently linked to atherosclerotic CVD in postmenopausal women, researchers found.

Women with early-onset MI had fewer recurrent major CV events during long-term follow-up compared with men, despite sex differences regarding disease burden and preventive treatments, researchers found.

Emily Barrows, MD, is an assistant professor in the department of obstetrics and gynecology at Virginia Commonwealth University.

The FDA recently granted 510(k) clearance for Jada System, a device its manufacturer said “rapidly controls and treats postpartum hemorrhage and abnormal postpartum uterine bleeding.”

Sex disparities continue in CV scientific leadership, as women are not often present in leadership roles of CV clinical trials published in major journals, researchers found.

Cardiologists and clinicians do not often recognize the sex-specific CVD pathophysiology in women, especially when using imaging modalities to diagnose patients, according to a speaker.

Menopause can be a good time to start addressing CVD risk reduction even though it should be discussed way before then, according to a presentation at the virtual Heart in Diabetes Conference.

Women with peripheral artery disease were more likely to have depressive symptoms compared with men, researchers found.

There are many ways in which women’s CV risk differs from that of men, and addressing it requires solutions tailored to women, according to a presentation at the virtual American Society for Preventive Cardiology Congress on CVD Prevention.